
Results 1 - 20 of 175 in Ranbaxy Laboratories
AstraZeneca makes peace with Teva to protect Nexium sales
... with a generics company over Nexium. Two years ago, it did a similar deal with the Indian company Ranbaxy Laboratories. Both Teva and Ranbaxy will now be able to start marketing a copy of Nexium in May 2014, the date on which AstraZeneca's first ... Comment?
Ranbaxy Laboratories in Talks to Acquire Bangalore Vaccine Company for Rs 50-cr
Indiatimes.com -- Ranbaxy Laboratories has started discussions to buy a privately-held Bangalore-based vaccine company, two persons familiar with the development said. Comment?
Ranbaxy launches anti-fungal chemical
MUMBAI: Drug major Ranbaxy Laboratories has launched a new chemical, Lulifin , used in the treatment of fungal infection. Comment?
Implanting new ideas into next generation depot syringes
Ranbaxy Laboratories has sold its Chinese JV, Ranbaxy Guangzhou China Limited , as part of a new approach to the country's rapidly expanding drug market. Comment?
China Biotech Week in Review: Year-End IPOs
... Medical (NYSE: CCM ) and China Cord Blood (NYSE: CO ) did not fare particularly well in their debuts. Ranbaxy Laboratories ( RBXLF.PK ) has sold its share in a China manufacturing JV, Ranbaxy Guangzhou China (RGCL), to HNG Chembio Pharmacy Co Ltd. ... Comment?
Ranbaxy launches anti-fungal chemical in India
Drug major Ranbaxy Laboratories today said it has launched a new chemical, Lulifin , used in the treatment of fungal infection. Comment?
Japan warms relations with India but future accord remains hazy
... the back of a series of successful tie ups. The Tata-DoCoMo tie-up and the Daiichi Sankyo venture with Ranbaxy Laboratories, perceptibly contributed to annual trade figures between the two countries and the success of the collaborations has seen the ... Comment?
Ranbaxy sells stake in Chinese joint venture
New Delhi, Dec. 29: Ranbaxy Laboratories has sold its entire stake in Chinese joint venture Ranbaxy Ghuangzhou China Limited to HNG Chembio Pharmacy Company for an undisclosed amount. Comment?
... Wednesday, Dec 30, 2009 at 0000 hrs IST Updated: Wednesday, Dec 30, 2009 at 0000 hrs IST Mumbai: Ranbaxy Laboratories has sold its entire stake in Chinese joint venture, Ranbaxy Ghuangzhou China (RGCL), to HNG Chembio Pharmacy Co Ltd for an ... Comment?
Ranbaxy exits Chinese joint venture
NEW DELHI: Ranbaxy Laboratories on Tuesday announced its exit from the Chinese joint venture stating it had sold its entire stake in the venture, Ranbaxy Ghuangzhou China, to HNG Chembio Pharmacy Co Ltd for an undisclosed amount. Comment?
Ranbaxy exits from China venture
Ranbaxy Laboratories has sold its entire stake in Chinese joint venture - Ranbaxy Guangzhou China Ltd - to HNG Chembio Pharmacy Co Ltd for an undisclosed amount. Comment?
Ranbaxy again feels FDA heat - this time over US plant
Delhi-based drug manufacturer Ranbaxy Laboratories has received a warning from the Food and Drug Administration over violation of good manufacturing practices norms at one of its manufacturing facilities in the US, the company said in a statement on Thursday. Comment?
FDA hauls up Ranbaxy US unit for deviations
... added. Ohm Laboratories Inc, based in North Brunswick, New Jersey, USA, is a wholly-owned subsidiary of Ranbaxy Laboratories Ltd. Ohm is engaged in sale and distribution of generic and branded private label, OTC products in the US healthcare system. ... Comment?
How top Indian drug firms are pushing up sales
... plans are to tap the Rs 80-crore scar and marks removal cream market in India. A few months ago, Ranbaxy Laboratories had in-licensed an anti-ageing drug Neuronox from Medy-Tox of South Korea. The market size for this drug in India is estimated at ... Comment?
MG Arun Posted: Wednesday, Dec 23, 2009 at 2054 hrs IST Updated: Wednesday, Dec 23, 2009 at 2054 hrs IST : The synergies between Ranbaxy Laboratories and its owner Daiichi Sankyo have been unravelling over the last few months, much to the relief of investors in the Indian company. Comment?
Big Pharma's Love-Hate With India
... are mostly independent and highly entrepreneurial, that compete in this area. The two exceptions are Ranbaxy Laboratories, which was bought by Japan's Daiichi Sankyo in 2007, and Matrix Pharmaceuticals, a subsidiary of generic drugmaker Mylan ( MYL ... Comment?
Ranbaxy to make presence in African region
CHENNAI: Daiichi Sankyo Company and Ranbaxy Laboratories have announced that Ranbaxy will launch Olmesartan Medoxomil, an anti-hypertensive, originally discovered by Daiichi Sankyo in six African countries. Comment?
Ranbaxy to launch anti-hypertensive drug in six African countries
Daiichi Sankyo Company Limited and Ranbaxy Laboratories Limited, today announced that Ranbaxy would launch Olmesartan Medoxomil, an anti-hypertensive drug originally synthesised by Daiichi Sankyo, in six African countries. Comment?
Ranbaxy to launch 'Olmesartan Medoxomil' in 6 African countries
New Delhi, Dec 21 : Pharma major Ranbaxy Laboratories Ltd will launch 'Olmesartan Medoxomil', an antihypertensive, in six African countries such as Kenya, Mozambique, Nigeria, Tanzania, Uganda and Zambia. Comment?
As molecule deals fall, pharma firms see cure in late licensing
... in their research and development spend in the days of economic slowdown," said an industry expert. Ranbaxy Laboratories, which became a subsidiary of Japanese drug major Daiichi Sankyo last year, had outlicensed a prostate enlargement drug ... Comment?